SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 1.210-14.2%3:27 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don W Stone who wrote ()9/30/1996 6:46:00 PM
From: andy harrison   of 82
 
Today Denmark approved NVX's DTaP IPV combinate vaccine. The first
of its kind in the world. NVX is way ahead of all competitors with
respect to the polio combinate vaccine. HMO's will flock to their
product to cut down on doctors office visits and to help with the
compliance problem. NVX will leapfrog competitors in Western Europe
and by late 1997-1998 bring the approved vaccine to the US market.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News